Sarah Wildenhain

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Todd A. Braciak, Claudia C. Roskopf, Sarah Wildenhain et al. · OncoImmunology · 2018 · 33 citations · Full text

CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells

Christian Schiller, Todd A. Braciak, Nadja C. Fenn et al. · Oncotarget · 2016 · 32 citations · Full text

The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells

Deborah Ingenhag, Sven Reister, Franziska Auer et al. · Haematologica · 2018 · 23 citations · Full text

Homeobox Protein HB9 Binds to the Prostaglandin E Receptor 2 Promoter and Inhibits Intracellular cAMP Mobilization in Leukemic Cells

Sarah Wildenhain, Deborah Ingenhag, Christian Rückert et al. · Journal of Biological Chemistry · 2012 · 21 citations · Full text

NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2

Todd A. Braciak, Sarah Wildenhain, Claudia C. Roskopf et al. · Journal of Translational Medicine · 2013 · 12 citations · Full text